№ files_lp_3_process_7_062522
File format: docx
Character count: 4241
File size: 59 KB
Application form for laboratory biosafety approval, detailing the procedures and requirements for the handling of biohazardous materials in laboratory settings.
Note:
Year
Subject:
Biosafety, Laboratory Approval
Document Type:
Application Form
Target Audience:
Researchers, Lab Managers
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2007
Region / City:
Putrajaya
Topic:
Biosafety
Document Type:
Form
Organization / Institution:
Department of Biosafety
Author:
N/A
Target Audience:
Institutions registered with the National Biosafety Board
Period of Validity:
N/A
Approval Date:
N/A
Date of Amendments:
N/A
Jurisdiction:
India
Subject:
Market surveillance measures for securities of companies under IBC
Scope:
Non-derivative securities and securities with derivative products
Stages:
IBC Stage I; IBC Stage II
Trigger Criteria:
Close-to-Close Price Variation thresholds over 5, 15, 30 trading days and 3 months
Additional Trigger:
Receipt of corporate announcement or disclosure from the company
Margin Requirement:
100% margin w.e.f. T+2 basis
Price Band:
±5%
Settlement Type:
Gross settlement
ASD Requirement:
100% Trade Value to be deposited by Buyer
Trading Frequency:
Once a week trading
Review Frequency:
Daily review for Stage I; Monthly review for Stage II
Exit Condition:
Movement based on minimum 1 month in respective stage and review on last trading day of the month
Restriction:
No upward movement permitted in Stage II
Non-Promoter Holding Condition:
Securities moved out after attainment of non-promoter holding ≥25% and completion of subsequent 3 calendar months
Year:
2024
Region / City:
India
Subject:
Bankruptcy and Insolvency
Document Type:
Legal Summary
Organ / Institution:
Vinod Kothari and Company
Author:
Vinod Kothari
Target Audience:
Legal professionals, financial creditors, insolvency practitioners
Period of Validity:
Until the next legal update
Approval Date:
17th January, 2024
Amendment Date:
3rd January, 2024
Year:
2024–2025
State:
California
Subject:
Health Facilities Building Code Amendments and Adoption
Document Type:
Commission Action Matrix
Agency:
Department of Health Care Access and Information (HCAI) / Office of Statewide Hospital Planning and Development (OSHPD)
Related Codes:
2025 California Building Code (CBC), Title 24, Part 2, Volume 1; 2024 International Building Code (IBC)
Committee:
Health Facilities (HF) Code Advisory Committee
Scope:
Adoption and amendment of IBC Chapters 1–11 for OSHPD 1, 1R, 2, 3, 4, 5 and 6
Action Categories:
CAC Actions; Agency Responses; CBSC Actions
Date Reference:
OSHPD 04/24
Color Legend:
GREEN (uncontested items), YELLOW (challenged items), SALMON (withdrawn, no action required)
Personal Information – Commercial Client Agreement(Suggested Language for IBC DASH – 30th June 2023)
Note:
Date
Year:
2023
Subject:
Personal Information, Insurance Policy, Underwriting Purposes, Analytics Purposes
Document Type:
Agreement
Target Audience:
Clients, Insurance Brokers
Note:
Year
Topic:
Corporate Insolvency, Valuation, Insolvency Professionals
Document Type:
Report
Institution:
SUNY Upstate Medical University
Platform:
IRBNet
Subject:
IRB and IBC submissions
Document Type:
Institutional instruction page
Related Committees:
Institutional Review Board (IRB); Institutional Biosafety Committee (IBC)
Year:
2024
Scope:
Research involving human subjects, recombinant or synthetic nucleic acid molecules, biohazardous and infectious agents
Associated Regulations:
NIH Guidelines; HIPAA policies
Intended Audience:
Researchers and study personnel
Content Includes:
Forms, templates, policies, training materials, meeting dates and deadlines, submission instructions
Access Method:
IRBNet Forms and Templates tab
Year:
2024
Event:
International Broadcasting Convention (IBC)
Location:
Amsterdam, Netherlands
Venue:
RAI Convention Centre
Subject:
Broadcasting industry exhibition and conference experience
Document type:
Personal event report
Author:
Tom Holland
Affiliation:
Solent University
Organisations mentioned:
IABM; BT Media and Broadcast; Sony; Ross Video; Netgear AV; NEP; TVB; Grass Valley; OBS; NBC Sports; SVG Europe; BEIN Media; SMPTE
Programme:
IABM Student Bursary Programme
Audience:
Broadcasting students and industry participants
Event duration described:
Four days
Travel route:
Southampton Airport – Amsterdam Schiphol Airport
Related events:
IABM Awards; Rise WIB drinks; SMPTE drinks
Topics discussed:
Broadcast technology; live production; IP transformation; disinformation in news; industry talent development; Olympic broadcasting technology; AI in sports broadcasting
Organization:
Institutional Biosafety Committee (IBC), Ann & Robert H. Lurie Children’s Hospital of Chicago
Document Type:
Administrative Form
Purpose:
Inactivation of an approved biosafety research protocol after project completion
Subject Area:
Biosafety and Biohazardous Research Oversight
Related Activities:
Research involving recombinant and synthetic nucleic acid molecules and biohazardous materials
Submission Method:
E-mail submission to [email protected]
Responsible Role:
Principal Investigator (PI)
Compliance Reference:
NIH Guide for the shipment and transfer of recombinant and synthetic nucleic acids
Key Declarations:
Confirmation of project completion, biosafety compliance, disposal of biohazards, and proper storage of biological agents
Required Fields:
Date of report, biosafety registration number, protocol title, PI name, PI email, investigator signature, date
Approval Authority:
Institutional Biosafety Committee
Year:
2024
Region / City:
Amsterdam
Topic:
Media Technology, Broadcasting
Document Type:
Report
Organization:
Rhein-Main University of Applied Sciences
Author:
Niklas Ehrenklau
Target Audience:
Students, Media Professionals
Period of Validity:
September 2024
Approval Date:
2024-09-12
Date of Changes:
None
Context:
Personal experience attending the IBC 2024 exhibition, highlighting industry innovations, networking opportunities, and specific product demonstrations.
Year:
2026
Organization:
Department of Agriculture, Fisheries and Forestry (DAFF)
Document type:
Policy / Procedure Manual
Version:
7.3
Scope:
Biosecurity industry participants
Audit types:
Probationary Audit Rate, Low Audit Rate
Compliance categories:
Critical non-compliance, Major non-compliance, Minor non-compliance
Key arrangement outcomes:
Containment, Isolation, Security, Identification, Traceability, Hygiene, Movement, Release, Awareness, Inspection, Treatment, Arrangement compliance, Notification, Supporting functions
Target audience:
Biosecurity industry participants
Fee structure:
On site $62/15min, Off site $37/15min
Reference conditions:
Biosecurity containment level 2 (BC2), Microbiological Class 5.2
Documented procedures:
Audit checklist, Site mapping, Signage, Access control, Waste storage
Year:
2020
Region / City:
USA
Topic:
Biosafety, Laboratory Systems, Public Health
Document Type:
Email Communication
Organization / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
Division of Laboratory Systems, CDC
Target Audience:
Laboratory professionals, clinicians, and leadership in rural and community hospitals
Period of Action:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
2025
Institution:
Click here to enter text
Reporting period:
1 January 2025 – 31 December 2025
Submission deadline:
1 March 2026
Document type:
Annual report
Responsible body:
Institutional Biosafety Committee (IBC)
Contact:
Department of Biosafety, [email protected]
Activities covered:
LMO/rDNA projects, modifications to approved projects, exempted activities, LMO storage, incidents and occupational disease records
Approval requirements:
Verification by IBC Chair, signed Declaration page
Format:
Soft copy with formal cover letter
Year:
Not specified
Region / City:
Not specified
Subject:
Laboratory biosafety
Document Type:
Manual
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Laboratory personnel, safety officers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Document type:
Reporting format
Legal framework:
Cartagena Protocol on Biosafety; Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress
Responsible organization:
Executive Secretary of the Convention on Biological Diversity
Target audience:
National focal points and relevant stakeholders
Period covered:
From [month/year] to [month/year]
Submission date:
[day/month/year]
Languages:
One of the six official United Nations languages
Instructions:
Online and offline submission options available
Mandatory questions:
Yes
Content focus:
National measures, biosafety integration, pharmaceuticals regulation, stakeholder consultation
Year:
2024
Note:
Region / City
Subject:
Institutional Biosafety
Document Type:
Self-Assessment Tool
Organ / Institution:
National Institutes of Health (NIH)
Author:
NIH Office of Science Policy (OSP)
Target Audience:
Institutional Biosafety Committees, Research Institutions
Year:
2018
Region / City:
Ithaca, New York
Topic:
Biological Safety
Document Type:
Risk Assessment
Institution:
Cornell University
Author:
Cornell University Environmental Health and Safety (EHS)
Target Audience:
Laboratory personnel, biosafety officers
Period of Effectiveness:
Ongoing
Approval Date:
January 2018
Amendment Date:
Not specified
Year:
2020
Region / City:
United States
Subject:
Biosafety, Laboratory Systems
Document Type:
Email Communication
Organization:
Centers for Disease Control and Prevention (CDC)
Author:
Division of Laboratory Systems, CDC
Target Audience:
Laboratory professionals, clinicians, leadership in rural and community hospital settings
Period of Validity:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2025
Note:
Region / City
Topic:
Biosafety
Document Type:
Manual
Institution / Organization:
National Institutes of Health (NIH), NAU Institutional Biosafety Committee (IBC)
Target Audience:
Laboratory Personnel, Principal Investigators (PIs)
Year:
2024
Note:
Region / City
Topic:
Biosafety
Document Type:
Report